Vol. 1 No. 1 (2022)

Published: 22-03-2022

View Vol. 1 No. 1 (2022)

Editorials

The night of randomized clinical trials where all patients are black: a need to estimate variability in treatment effects

Giovanni de Gaetano, Chiara Cerletti, Licia Iacoviello, Maria Benedetta Donati

https://doi.org/10.4081/btvb.2022.24

1575

PDF: 197
- PDF

Invited Editorials

Are platelets more than a model of brain neurons?

Ilaria Canobbio, Silvia Stella Barbieri

https://doi.org/10.4081/btvb.2022.29

360

PDF: 198
- PDF
Is transient ischemic attack a minor stroke?

Ettore Dolcetti, Antonio Bruno, Diego Centonze

https://doi.org/10.4081/btvb.2022.31

323

PDF: 166
- PDF
Moving beyond p-value

Augusto Di Castelnuovo, Licia Iacoviello

https://doi.org/10.4081/btvb.2022.30

1906

PDF: 343
- PDF
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

Marco P. Donadini, Walter Ageno

https://doi.org/10.4081/btvb.2022.22

1845

PDF: 438
- PDF
Gene transfer in hemophilia A: not cogent yet

Pier Mannuccio Mannucci

https://doi.org/10.4081/btvb.2022.32

1781

PDF: 173
- PDF

Reviews

The Von Willebrand factor-ADAMTS-13 axis: a two-faced Janus in bleeding and thrombosis

Stefano Lancellotti, Monica Sacco, Maira Tardugno, Antonietta Ferretti, Raimondo De Cristofaro

https://doi.org/10.4081/btvb.2022.11

1697

PDF: 249
- PDF

Narrative Reviews

An ecological alliance against air pollution and cardiovascular disease

Pier Mannuccio Mannucci

https://doi.org/10.4081/btvb.2022.21

1585

PDF: 193
- PDF
New perspectives for prevention of the post-thrombotic syndrome

Paolo Prandoni

https://doi.org/10.4081/btvb.2022.20

1128

PDF: 365
- PDF

Original Articles

Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care

Gianfranco De Girolamo, Luca Sarti, Sonia Cecoli, Karin Bonora, Chiara Ajolfi, Francesco Bellelli, Valeria Coluccio, Gualtiero Palareti, Marco Marietta

https://doi.org/10.4081/btvb.2022.9

433

PDF: 161

Supplementary Files: 44
- PDF
- Supplementary Files

Study Protocols

Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli

https://doi.org/10.4081/btvb.2022.10

713

PDF: 256

APPENDIX: 44
- PDF
- APPENDIX

© PAGEPress 2008-2024 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy